New search    Hide text from Guidelines

The group is subdivided according to mode of action.

M04AA Preparations inhibiting uric acid production

Combinations of allupurinol and other antigout preparations are classified here.
Rasburicase for the treatment of hyperuricemia is classified in V03AF.

M04AB Preparations increasing uric acid excretion
M04AC Preparations with no effect on uric acid metabolism

Colchinine indicated for the reduction of atherothrombotic events is also classified in M04AC01.

M04AX Other antigout preparations

This group comprises preparations which cannot be classified in the preceding groups.